These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 33711753)

  • 1. The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19.
    Jiménez-Soto R; Aguilar-Soto M; Rodríguez-Toledo CA; Camiro-Zúñiga A; Demichelis R;
    Thromb Res; 2021 Jun; 202():14-16. PubMed ID: 33711753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia.
    Nadeem R; Kamat S
    Chest; 2021 Jul; 160(1):e94-e95. PubMed ID: 34246406
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
    Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.
    Billett HH; Reyes-Gil M; Szymanski J; Ikemura K; Stahl LR; Lo Y; Rahman S; Gonzalez-Lugo JD; Kushnir M; Barouqa M; Golestaneh L; Bellin E
    Thromb Haemost; 2020 Dec; 120(12):1691-1699. PubMed ID: 33186991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin's potential mechanisms against SARS-CoV-2.
    Afsharirad B; Entezari-Maleki T
    Int J Surg; 2023 Jan; 109(1):48-49. PubMed ID: 36799791
    [No Abstract]   [Full Text] [Related]  

  • 6. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic anticoagulation in COVID-19 patients.
    Belfaqeeh O; Patel J; Janapala RN; Pourmand A
    Thromb Res; 2021 Dec; 208():213. PubMed ID: 33610333
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?
    Becker RC; Ortel TL
    JAMA Intern Med; 2023 Jun; 183(6):532-533. PubMed ID: 36946227
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic anticoagulation in COVID-19 patients.
    Lemos ACB; do Espírito Santo DA; Miranda CH
    Thromb Res; 2021 Jul; 203():72-73. PubMed ID: 33964522
    [No Abstract]   [Full Text] [Related]  

  • 10. When to use anticoagulation in COVID-19.
    Moll M; Connors JM
    Thromb Res; 2021 Aug; 204():136-137. PubMed ID: 34176588
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing Anticoagulation for COVID-19-Related Lung Transplantation.
    Fox WE; Patel J; Cross MW; McNeil JS; Raphael J; Blank RS
    J Cardiothorac Vasc Anesth; 2023 Feb; 37(2):334-335. PubMed ID: 36414531
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature.
    Aamir Waheed M; Rashid K; Rajab T; Rajab A; Adnan AH; Fayyaz H; Ibad AA; Basri R; Khan Y; Alhabib HI; Elzouki A
    Saudi Med J; 2022 Jun; 43(6):541-550. PubMed ID: 35675936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Patient Selection for the Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019.
    Nishioka A; Imamura T
    Crit Care Med; 2021 Nov; 49(11):e1182. PubMed ID: 34048372
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
    Bikdeli B; Talasaz AH; Rashidi F; Bakhshandeh H; Rafiee F; Rezaeifar P; Baghizadeh E; Matin S; Jamalkhani S; Tahamtan O; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Khalili H; Yadollahzadeh M; Riahi T; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Amin A; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Dobesh PP; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
    Thromb Haemost; 2022 Jan; 122(1):131-141. PubMed ID: 33865239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities.
    Mujahid N; Rajan A; Abul Y; Vura NVRK; Neupane I; LaPlante K; Gravenstein S
    Aging Clin Exp Res; 2022 Dec; 34(12):3171-3177. PubMed ID: 36434429
    [No Abstract]   [Full Text] [Related]  

  • 18. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
    Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.